DrugOct 2, 2024
AbbVie Refresh P.M recall — FDA D-0664-2024
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Class IIFDA: OngoingAbbVie Inc.
Recall history in this database
Classification mix: Class II: 8, Class III: 2.
DrugOct 2, 2024
AbbVie Refresh LACRI-LUBE recall — FDA D-0665-2024
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Class IIFDA: OngoingAbbVie Inc.
DrugNov 15, 2023
SYNTHROID recall — FDA D-0088-2024
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
Class IIIFDA: OngoingAbbVie Inc.
DrugNov 1, 2017
AbbVie AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone recall — FDA D-0033-2018
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
Class IIIFDA: TerminatedAbbVie Inc.
DrugMar 8, 2017
Duopa recall — FDA D-0495-2017
Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing…
Class IIFDA: TerminatedAbbVie Inc.
DrugMay 7, 2014
Lupron Depot recall — FDA D-1287-2014
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Class IIFDA: TerminatedAbbVie Inc.
DrugMay 7, 2014
Lupron Depot recall — FDA D-1291-2014
Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.
Class IIFDA: TerminatedAbbVie Inc.
DrugMay 7, 2014
Lupron Depot recall — FDA D-1290-2014
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Class IIFDA: TerminatedAbbVie Inc.
DrugMay 7, 2014
LUPRON DEPOT-PED recall — FDA D-1289-2014
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Class IIFDA: TerminatedAbbVie Inc.
DrugMay 7, 2014
Lupron Depot recall — FDA D-1288-2014
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Class IIFDA: TerminatedAbbVie Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies AbbVie Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.